FOR IMMEDIATE RELEASE
Co-founder and CTO Glen de Vries to Discuss Future of
Clinical Data Management at International Conference
NEW YORK, NY – March 20, 2007 – Medidata Solutions, a global provider of electronic clinical data capture, management and reporting solutions, today announced that the company’s Co-founder and Chief Technology Officer Glen de Vries will offer insights into future technologies and processes in clinical development at an upcoming conference in Korea.
International Symposium on Clinical Trials
March 23, 2007, Chonbuk National University Hospital, Seoul, Korea
Session Title: “The Future of Data Management in Clinical Trials”
March 23, 1:30 p.m.
In this presentation, de Vries will address data management in clinical trials with a focus on adaptive methodologies within the scope of both single clinical trials and the management of multiple compounds and portfolios. This presentation will provide a look at the increasing adoption of EDC and how prospective cleaning and analysis of data will continue to enhance earlier decision making and collaboration across geographic and linguistic borders. Additionally, de Vries will highlight how the roles of monitors and data managers may evolve as EDC and clinical data management systems merge, and as electronic health records are used as a direct source of subject data.
About Glen de Vries
Glen is one of the founders of Medidata Solutions and has filled the role of chief technology officer since 1999. He is the lead architect of the Medidata Rave system and has grown Medidata’s Research & Development team to include top talent from the clinical research community, banking and enterprise resource planning industries.
Prior to his work with Medidata Solutions, Glen’s pioneering efforts in online physician/patient relationships were featured by The New York Times and drew the attention of the Office of Health and Human Services. He has more than 10 years of experience in medical software development, including electronic health records and consumer-targeted products.
Glen has been a featured presenter at multiple Drug Information Association (DIA) meetings in the U.S., as well as DIA Japan, SCDM, Bio-IT World, BIOPHEX, Partnerships with CROs, the National Medical Association Annual Meeting and American Urological Association Annual Meetings.
About Medidata Solutions Worldwide
Medidata Solutions helps the world’s leading pharmaceutical, biotechnology, medical device and research organizations maximize the value of their clinical research investments. Innovative process design, technology and services streamline clinical trials by providing early visibility to reliable clinical data—the lifeblood of every research organization. Working with companies and institutions both large and small, Medidata Solutions helps clinical researchers safely accelerate the process of bringing life-enhancing treatments to market—on six continents and in more than 80 countries. Medidata Solutions brings significant value to its broad client base with deep clinical experience and expertise in more than 20 therapeutic areas, projects in Phase I, II, III, IV, registries and surveillance, and studies with thousands of investigators and tens-of-thousands of subjects. For more information, please visit www.mdsol.com.
Contact:
Susan Lombardo
Lois Paul & Partners
781.782.5767
Susan_Lombardo@lpp.com